David I. Meyer
Chief Executive Officer at Los Angeles Biomedical Research Institute at Harbor-UCLA
David I. Meyer active positions
| Companies | Position | Start | End |
|---|---|---|---|
Los Angeles Biomedical Research Institute at Harbor-UCLA
 Los Angeles Biomedical Research Institute at Harbor-UCLA BiotechnologyHealth Technology Los Angeles Biomedical Research Institute at Harbor-UCLA, also known as the Lundquist Institute, is a non-profit research organization located in Torrance, CA. The institute has also started working on a vaccine for the urgent fungal threat, Candida auris, which is spreading at an alarming rate throughout healthcare facilities in the US and is resistant to several antifungal drugs. The institute focuses on biomedical research, clinical trials, and community outreach programs. The institute has various research theme groups and researchers working on different projects, including the Institute for Translational Genomics and Population Sciences, which contributes to new research in genomics. The Lundquist Institute has received several grants and gifts for its research, including a $1.50 million gift from Farima and Joseph Czyzyk for the Diagnostic and Wellness Center. The CEO of the private company is David I. Meyer. | Chief Executive Officer | - | - |
| President | - | - |
Career history of David I. Meyer
Statistics
International
| United States | 2 |
Operational
| Chief Executive Officer | 1 |
| President | 1 |
Sectoral
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Los Angeles Biomedical Research Institute at Harbor-UCLA
Los Angeles Biomedical Research Institute at Harbor-UCLA BiotechnologyHealth Technology Los Angeles Biomedical Research Institute at Harbor-UCLA, also known as the Lundquist Institute, is a non-profit research organization located in Torrance, CA. The institute has also started working on a vaccine for the urgent fungal threat, Candida auris, which is spreading at an alarming rate throughout healthcare facilities in the US and is resistant to several antifungal drugs. The institute focuses on biomedical research, clinical trials, and community outreach programs. The institute has various research theme groups and researchers working on different projects, including the Institute for Translational Genomics and Population Sciences, which contributes to new research in genomics. The Lundquist Institute has received several grants and gifts for its research, including a $1.50 million gift from Farima and Joseph Czyzyk for the Diagnostic and Wellness Center. The CEO of the private company is David I. Meyer. | Health Technology |
- Stock Market
- Insiders
- David I. Meyer
- Experience
